MEDP

NASDAQ Healthcare

Medpace Holdings, Inc. - Common Stock

Diagnostics & Research

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

�� 市场数据

价格	$520.60
成交量	627,237
市值	14.87B
贝塔系数	1.390
RSI（14日）	75.3 超买
200日均线	$506.34
50日均线	$471.52
52周最高	$628.92
52周最低	$250.05
市盈率	33.70
Forward P/E	27.06
Price / Book	32.17